Scarica l'app Stockscreener
1.89
0.53%
0.01
Precedente Chiudi:
$1.88
Aprire:
$1.83
Volume 24 ore:
56,557
Relative Volume:
0.29
Capitalizzazione di mercato:
$100.04M
Reddito:
$697.00K
Utile/perdita netta:
$-39.78M
Rapporto P/E:
-1.1317
EPS:
-1.67
Flusso di cassa netto:
$-8.90M
1 W Prestazione:
+12.50%
1M Prestazione:
+33.10%
6M Prestazione:
-0.53%
1 anno Prestazione:
+32.17%
Intervallo 1D:
$1.8114
$1.9493
Intervallo di 1 settimana:
$1.62
$2.04
Portata 52W:
$1.28
$3.19
Rafael Holdings Inc Stock (RFL) Company Profile
Nome
Rafael Holdings Inc
Settore
Industria
Telefono
212-658-1450
Indirizzo
520 BROAD STREET, NEWARK
Confronta RFL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RFL
Rafael Holdings Inc
|
1.89 | 100.04M | 697.00K | -39.78M | -8.90M | -1.67 |
|
CBRE
Cbre Group Inc
|
143.18 | 39.60B | 36.74B | 1.01B | 1.35B | 3.27 |
|
CSGP
Costar Group Inc
|
82.12 | 34.20B | 2.81B | 117.20M | -30.60M | 0.29 |
|
BEKE
Ke Holdings Inc Adr
|
17.67 | 22.71B | 12.30B | 566.18M | 1.32B | 0.4805 |
|
JLL
Jones Lang Lasalle Inc
|
260.64 | 11.28B | 24.05B | 536.00M | 508.40M | 11.06 |
|
FSV
Firstservice Corp
|
178.79 | 8.17B | 4.93B | 108.16M | 203.45M | 2.40 |
Rafael Holdings Inc Borsa (RFL) Ultime notizie
Rafael to continue phase 3 study of NPC treatment after DMC review - Investing.com Nigeria
Rafael Holdings Advances Phase 3 Study for NPC1 Treatment - TipRanks
Major Breakthrough: Phase 3 Trial for Fatal Rare Disease NPC1 Gets Critical DMC Approval to Continue - Stock Titan
Rafael Holdings, Inc. (NYSE:RFL) Short Interest Update - MarketBeat
Howard S. Jonas Acquires 13,080,457 Shares of Rafael Holdings, Inc. (NYSE:RFL) Stock - MarketBeat
Rafael Holdings Up 29%, Insider Buyers Are Up 61% - Yahoo Finance
Retail investors invested in Rafael Holdings, Inc. (NYSE:RFL) up 29% last week, insiders too were rewarded - simplywall.st
Rafael Holdings Reports Improved Financial Results and Strategic Progress - TipRanks
Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2025 - MarketScreener
Rafael Holdings, Inc. SEC 10-Q Report - TradingView
Rafael (NYSE:RFL) Posts Quarterly Earnings Results - MarketBeat
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results - The Manila Times
Rafael Holdings Slashes Losses 85% as Crucial Phase 3 Rare Disease Trial Results Loom - Stock Titan
Rafael Holdings stock surges after CEO acquires $16.7m in shares - Investing.com Nigeria
Rafael Holdings stock surges after CEO acquires $16.7m in shares By Investing.com - Investing.com South Africa
Rafael Holdings Completes $25M Rights Offering - TipRanks
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering - The Manila Times
RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics - The Manila Times
Rafael Holdings Announces Final Results And Closing Of Rights Offering - MarketScreener
Rafael CEO Backs $25M Rights Offering to Fund Critical Phase 3 Rare Disease Drug Trial - Stock Titan
Israel Defense Exports Hit Record in 2024 as Europe Demand Jumps - Bloomberg
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer - The Manila Times
Rafael (NYSE:RFL) Trading Up 2.6% – Still a Buy? - Defense World
Protara Therapeutics names new Chief Commercial Officer By Investing.com - Investing.com India
Cancer Drug Veteran Behind Trodelvy Launch Joins Protara as Commercial Chief to Lead Market Strategy - Stock Titan
RFL stock touches 52-week low at $1.28 amid market challenges - Investing.com Australia
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trap - The Manila Times
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody - The Manila Times
Rafael Holdings Rights Offering: $25M Deal Terms Revealed, May 29 Deadline Approaches - Stock Titan
Ekso Bionics reports Q1 results, plans reverse stock split - The North Bay Business Journal
Ekso Bionics Accepted into NVIDIA Connect Program - Quantisnow
Dassault Aviation Shares Continue to Drop After the Rafale Jet Shot Down - TECHi
Rafael : to Present at LD Micro Investor Conference - marketscreener.com
Rafael Holdings Enters Standby Purchase Agreement with Chairman - TipRanks
SEC Form 424B3 filed by Rafael Holdings Inc. - Quantisnow
Ekso Bionics: Q1 Earnings Snapshot - CTPost
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - ADVFN
Rafael announces revised subscription rights in connection with offering - TipRanks
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously ... - Bluefield Daily Telegraph
Rafael Holdings Launches $25M Rights Offering: Key Dates and Terms Investors Must Know - Stock Titan
Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World
Upcoming Stock Splits This Week (May 5 to May 9) – Stay Invested - TipRanks
Press Release Distribution & PR Platform - ACCESS Newswire
LD Micro 360 Companies: --Set to Present this Week. - ACCESS Newswire
Metric Deep Dive: Understanding Rafael Holdings Inc (RFL) Through its Ratios - DWinneX
Tronox Holdings plc: Navigating Market Fluctuations with a 857.28M Market Cap - investchronicle.com
Rafael Holdings Inc (RFL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Sonoco Reports First Quarter 2025 Results - The Manila Times
Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan
Rafael Holdings Inc Azioni (RFL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):